These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 18929829)

  • 21. Ex vivo culture of human CD34+ cord blood cells with thrombopoietin (TPO) accelerates platelet engraftment in a NOD/SCID mouse model.
    van Hensbergen Y; Schipper LF; Brand A; Slot MC; Welling M; Nauta AJ; Fibbe WE
    Exp Hematol; 2006 Jul; 34(7):943-50. PubMed ID: 16797422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on hematopoietic reconstitution by ex vivo expanded human cord blood hematopoietic stem/progenitor cells in SCID mice].
    Liu Y; Pei X; Lu S
    Zhonghua Xue Ye Xue Za Zhi; 1999 Dec; 20(12):634-6. PubMed ID: 11721365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells.
    Jang YK; Jung DH; Jung MH; Kim DH; Yoo KH; Sung KW; Koo HH; Oh W; Yang YS; Yang SE
    Ann Hematol; 2006 Apr; 85(4):212-25. PubMed ID: 16391912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of growth factor conditions that reduce ex vivo cord blood progenitor expansion but do not alter human repopulating cell function in vivo.
    Levac K; Karanu F; Bhatia M
    Haematologica; 2005 Feb; 90(2):166-72. PubMed ID: 15710567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinically relevant expansion of hematopoietic stem cells with conserved function in a single-use, closed-system bioprocess.
    Madlambayan GJ; Rogers I; Purpura KA; Ito C; Yu M; Kirouac D; Casper RF; Zandstra PW
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1020-30. PubMed ID: 17084368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial transplantations in nonobese diabetic/severe combined immunodeficiency mice of transduced human CD34+ cord blood cells: efficient oncoretroviral gene transfer and ex vivo expansion under serum-free conditions.
    Gammaitoni L; Lucchi S; Bruno S; Tesio M; Gunetti M; Pignochino Y; Migliardi G; Lazzari L; Aglietta M; Rebulla P; Piacibello W
    Stem Cells; 2006 May; 24(5):1201-12. PubMed ID: 16410386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human CD34+ CD11b- cord blood stem cells generate in vitro a CD34- CD11b+ subset that is enriched in langerin+ Langerhans dendritic cell precursors.
    Soulas C; Arrighi JF; Saeland S; Chapuis B; Kindler V
    Exp Hematol; 2006 Nov; 34(11):1471-9. PubMed ID: 17046566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced engraftment of human cells in RAG2/gammac double-knockout mice after treatment with CL2MDP liposomes.
    Rozemuller H; Knaän-Shanzer S; Hagenbeek A; van Bloois L; Storm G; Martens AC
    Exp Hematol; 2004 Nov; 32(11):1118-25. PubMed ID: 15539091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Competitive repopulation assay of two gene-marked cord blood units in NOD/SCID/gammac(null) mice.
    Yahata T; Ando K; Miyatake H; Uno T; Sato T; Ito M; Kato S; Hotta T
    Mol Ther; 2004 Nov; 10(5):882-91. PubMed ID: 15509506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of human B cells from CD34+CD38- T- B- progenitors in organ culture by sequential cytokine stimulation.
    DeLuca D; Basye JL; Schumacher MJ; Lebsack TW
    Dev Comp Immunol; 2006; 30(11):1084-98. PubMed ID: 16581123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T lymphocytes determine the development of xeno GVHD and of human hemopoiesis in NOD/SCID mice following human umbilical cord blood transplantation.
    Verlinden SF; Mulder AH; de Leeuw JP; van Bekkum DW
    Stem Cells; 1998; 16 Suppl 1():205-17. PubMed ID: 11012164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesenchymal stem/progenitor cells in human umbilical cord blood as support for ex vivo expansion of CD34(+) hematopoietic stem cells and for chondrogenic differentiation.
    Wang JF; Wang LJ; Wu YF; Xiang Y; Xie CG; Jia BB; Harrington J; McNiece IK
    Haematologica; 2004 Jul; 89(7):837-44. PubMed ID: 15257936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refreezing of cord blood hematopoietic stem cells for allogenic transplantation: in vitro and in vivo validation of a clinical phase I/II protocol in European and Italian Good Manufacturing Practice conditions.
    Gunetti M; Ferrero I; Rustichelli D; Berger M; Gammaitoni L; Timeus F; Piacibello W; Aglietta M; Fagioli F
    Exp Hematol; 2008 Feb; 36(2):235-43. PubMed ID: 18206730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a human adaptive immune system in cord blood cell-transplanted mice.
    Traggiai E; Chicha L; Mazzucchelli L; Bronz L; Piffaretti JC; Lanzavecchia A; Manz MG
    Science; 2004 Apr; 304(5667):104-7. PubMed ID: 15064419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cell factor improves SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model.
    Zheng Y; Sun A; Han ZC
    Bone Marrow Transplant; 2005 Jan; 35(2):137-42. PubMed ID: 15543197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The plant mannose-binding lectin NTL preserves cord blood haematopoietic stem/progenitor cells in long-term culture and enhances their ex vivo expansion.
    Li K; Ooi VE; Chuen CK; Lam AC; Ooi LS; Zhang XB; Tsang KS; Chiu LC; Chan KY; Li CK; Fok TF; Yuen PM; Ng PC
    Br J Haematol; 2008 Jan; 140(1):90-8. PubMed ID: 17908183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experimental study on ex vivo expansion of CD(34)(+) umbilical cord blood cells].
    Qiu L; Herzig RH
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):417-20. PubMed ID: 11877015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a lineage-negative stem-progenitor cell population optimized for ex vivo expansion and enriched for LTC-IC.
    Forraz N; Pettengell R; McGuckin CP
    Stem Cells; 2004; 22(1):100-8. PubMed ID: 14688396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Differential study on the in vivo homing potential of human hematopoietic stem/progenitor cells from different sources in xenotransplanted NOD/SCID mouse model].
    Yang Z; Lu SH; Li YH; Liu B; Wang HJ; Jia HR; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):391-5. PubMed ID: 17939405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.